Preclinical models have shown that AR-FL and AR-V7 overexpression is associated with induction of a mesenchymal or stem-like phenotype known to promote metastasis [21–24], and death from prostate cancer is almost uniformly due to complications associated with metastasis. The gene discussed is AR; the disease is prostate cancer.